These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 335758)

  • 1. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypogonadism, galactorrhoea and hyper-prolactinaemia: Evaluation of pituitary gonadotrophins reserve before and under bromocriptine.
    Asfour M; L'Hermite M; Hedouin-Quincampoix M; Fossati P
    Acta Endocrinol (Copenh); 1977 Apr; 84(4):738-49. PubMed ID: 322432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin and gonadotrophin levels before and after luteinizing hormone-releasing hormone in the investigation of amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Br J Obstet Gynaecol; 1978 Dec; 85(12):945-56. PubMed ID: 367427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperprolactinaemia and female infertility.
    Godó G
    Acta Med Hung; 1984; 41(4):185-93. PubMed ID: 6440115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raised serum prolactin levels in amenorrhoea.
    Seppălă M; Hibroven E; Ranta T; Virkkunen P; Leppăluoto J
    Br Med J; 1975 May; 2(5966):305-6. PubMed ID: 1093605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin studies in "functionless" pituitary tumours.
    Child DF; Nader S; Mashiter K; Kjeld M; Banks L; Fraser TR
    Br Med J; 1975 Mar; 1(5958):604-6. PubMed ID: 1092408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S; Murray MA; Jequier AM; Steele SJ; Nabarro JD; Jacobs HS
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):597-607. PubMed ID: 1104218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal twenty-four hour pattern of pulsatile luteinizing hormone secretion and the response to naloxone in women with hyperprolactinaemic amenorrhoea.
    Tay CC; Glasier AF; Illingworth PJ; Baird DT
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):599-606. PubMed ID: 8252751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperprolactinaemic amenorrhoea--results of treatment with bromocriptine.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol Suppl (Copenh); 1978; 216():147-64. PubMed ID: 347859
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary responses to synthetic luteinizing hormone-releasing hormone in thirty-four cases of amenorrhea or oligomenorrhea associated with galactorrhea.
    van Campenhout J; Papas S; Blanchet P; Wyman H; Somma M
    Am J Obstet Gynecol; 1977 Apr; 127(7):723-8. PubMed ID: 322489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oestrogen modulation of gonadotrophin and prolactin release in women with anovulation and their responses to clomiphene.
    Kandeel FR; Butt WR; Rudd BT; Lynch SS; London DR; Edwards RL
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):619-35. PubMed ID: 383317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin and prolactin pulsations in hyperprolactinemic women before and during bromocriptine therapy.
    Klibanski A; Beitins IZ; Merriam GR; McArthur JW; Zervas NT; Ridgway EC
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1141-7. PubMed ID: 6427260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CB-154 (2 Br-a-ergocryptine) on serum follicle stimulating hormone, luteinzing hormone and prolactin in women with the amenorrhoea-galactorrhoea syndrome.
    Seki K; Seki M; Okumura T
    Acta Endocrinol (Copenh); 1975 May; 79(1):25-33. PubMed ID: 1173307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperprolactinemia in relation to galactorrhea and amenorrhea].
    Zhang LZ
    Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):218-21. PubMed ID: 6426895
    [No Abstract]   [Full Text] [Related]  

  • 20. The borderline pituitary fossa in patients with amenorrhoea and/or galactorrhoea.
    Banna M; Nicholas W; McLachlan M
    Neuroradiology; 1978; 16():440-2. PubMed ID: 570652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.